Scilex Holding (SCLX) Income towards Parent Company (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Income towards Parent Company of -$45.6 million for Q1 2026, down 75.04% year-over-year from -$182.9 million in Q1 2025, and up 0.99% on a QoQ basis from -$46.1 million in Q4 2025.

Scilex Holding (SCLX) Income towards Parent Company (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Income towards Parent Company for 7 consecutive years, with -$45.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income towards Parent Company fell 75.04% year-over-year to -$45.6 million; the TTM figure through Mar 2026 stood at -$393.6 million (down 428.28% YoY), while the FY2025 annual figure was -$374.1 million, down 413.76% from the prior year.
  • Income towards Parent Company came in at -$45.6 million for Q1 2026 at Scilex Holding, up from -$46.1 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $21.5 million in Q3 2022, with the low at -$257.8 million in Q3 2025.
  • Average Income towards Parent Company over 5 years is -$37.1 million, with a median of -$26.1 million recorded in 2025.
  • The largest YoY upside for Income towards Parent Company was 7736.6% in 2022 against a maximum downside of 10688.09% in 2022.
  • Year by year, Income towards Parent Company stood at -$17.9 million in 2022, then decreased by 19.66% to -$21.4 million in 2023, then jumped by 69.81% to -$6.5 million in 2024, then sank by 613.7% to -$46.1 million in 2025, then advanced by 0.99% to -$45.6 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$45.6 million, -$46.1 million, and -$257.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -45.65 Mn
Dec 31, 2025 -46.11 Mn
Sep 30, 2025 -257.82 Mn
Jun 30, 2025 -44.05 Mn
Mar 31, 2025 -26.08 Mn
Dec 31, 2024 -6.46 Mn
Sep 30, 2024 -4.39 Mn
Jun 30, 2024 -37.58 Mn
Mar 31, 2024 -24.38 Mn
Dec 31, 2023 -21.40 Mn
Sep 30, 2023 -35.53 Mn
Jun 30, 2023 -26.65 Mn
Mar 31, 2023 -30.75 Mn
Dec 31, 2022 -17.88 Mn
Sep 30, 2022 21.50 Mn
Jun 30, 2022 -17.84 Mn
Mar 31, 2022 -9.14 Mn
Dec 31, 2021 -35.26 Mn
Sep 30, 2021 -281,552.00
Jun 30, 2021 -165,349.00